Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Dorner Tablets in combination with aspirin for prevention of arteriosclerosis p…
-
CLINICAL_TRIALS research · 2016-06-21Clinical Trial Update: The Role of Arachidonic Acid Metabolites, From Patients With Metabolic Syndrome
Clinical trial update investigating the role of arachidonic acid metabolites in patients with metabolic syndrome, including Type 2 Diabetes …
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Konjac-Glucomannan Fibre Blend and American Ginseng in Type 2 Diabetes [Phase 2]
Phase 2 clinical trial evaluating a konjac-glucomannan fibre blend with American ginseng in type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: The Correlation Between the Retrobulbar Hemodynamics and Intrarenal Hemodynamics in T2DM Patients During the Early Period
A completed clinical trial assessing the relationship between retrobulbar and intrarenal hemodynamics in patients with Type 2 diabetes melli…
-
FDA approval · 2016-06-17FDA Approved: BASAGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for BASAGLAR KWIKPEN (insulin glargine) by Eli Lilly and Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Effect of the Anti-oxidant N-acetylcysteine on Beta-cell Function in Type 2 Diabetes [NA]
A completed clinical trial evaluated the effect of N-acetylcysteine on beta-cell function in Type 2 diabetes mellitus; results were posted i…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Southeastern Diabetes Initiative Clinical Intervention [NA]
This entry reports the completion of the Southeastern Diabetes Initiative Clinical Intervention trial (NCT01965639) sponsored by Duke Univer…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Lifestyle Intervention for Diabetes and Weight Management in Psychosis [NA]
A completed clinical trial evaluating a lifestyle intervention for diabetes management and weight loss in individuals with psychotic disorde…
-
CLINICAL_TRIALS trial_result · 2016-06-16Clinical Trial Update: The Effect of DPP4 Inhibitor on Vasclular Healing [Phase 4]
Phase 4 clinical trial evaluating the effect of a DPP-4 inhibitor on vascular healing in patients with acute coronary syndrome and type 2 di…
-
CLINICAL_TRIALS trial_result · 2016-06-15Clinical Trial Update: Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 safety, tolerability, pharmacokinetic and pharmacodynamic study of PF-06291874 as oral monotherapy in adults with type 2 diabetes me…
-
FDA approval · 2016-06-14FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the dapagliflozin and metformin hydrochloride combination product by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Negative Postprandial Effect on Endothelium After a Not-healthy Meal in Type 2 Diabetes as Affected by Training [NA]
This clinical trial update investigates whether physical training modifies the negative postprandial effect of an unhealthy meal on endothel…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients [Phase 4]
This Phase 4 clinical trial update investigates metabolomic variations in patients with Type 2 diabetes mellitus treated with saxagliptin.
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: The Correlation Between the Pulmonary Function and Intrarenal Hemodynamics in 37 T2DM Patients in Early Period
This completed study explored the correlation between pulmonary function and intrarenal hemodynamics in 37 patients with Type 2 diabetes mel…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Time Efficient Exercise in Type 2 Diabetes [NA]
The clinical trial 'Time Efficient Exercise in Type 2 Diabetes' has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy [NA]
This clinical trial update notes a completed study evaluating the effect of alogliptin on pulmonary function in obese patients with type 2 d…
-
FDA approval · 2016-06-09FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Losartan Potassium (generic) from Lupin Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Investigating the Effects of Glucodia™ on Glucose Parameters, Triglycerides and Body Weight [Phase 2]
A Phase 2 clinical trial evaluating the effects of Glucodia on glucose parameters, triglycerides, and body weight has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Fecal Microbiota Transplantation for Diabetes Mellitus Type II in Obese Patients [Phase 2]
Phase 2 clinical trial evaluating fecal microbiota transplantation for type 2 diabetes mellitus in obese patients; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Propolis Improves Glycemic Control in Subjects With Type 2 Diabetes and Chronic Periodontitis [Phase 4]
Phase 4 study investigating propolis for glycemic control in adults with Type 2 diabetes mellitus and chronic periodontitis. The trial statu…
-
EMA withdrawal · 2016-06-08EMA Expired: Avandia (rosiglitazone) — SmithKline Beecham Plc
Expired European marketing authorization for Avandia (rosiglitazone) by SmithKline Beecham Plc, for type 2 diabetes mellitus.
-
EMA withdrawal · 2016-06-08EMA Expired: Avandamet (rosiglitazone;metformin hydrochloride) — SmithKline Beecham Plc
Expired status for Avandamet (rosiglitazone/metformin) indicating it is no longer active in the market in the EMA record.
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: Study of the Relationship Between Blood Vessels and Insulin Response in Adolescents
A completed clinical trial explored the relationship between blood vessel function and insulin response in adolescents, including subjects w…
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise [Phase 3]
A Phase 3 Japanese study evaluating rimonabant in obese patients with type 2 diabetes on diet and exercise was terminated.
-
CLINICAL_TRIALS research · 2016-06-08Clinical Trial Update: Acute Effect of Phototherapy With Light Emitting Diode (LED) on Muscle and Pulmonary Oxygen Consumption on Diabetes Mellitus [NA]
This clinical trial update investigates the acute effects of LED phototherapy on muscle and pulmonary oxygen consumption in individuals with…